Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M68.9Revenue $M0.3Net Margin (%)-7,175.9Altman Z-Score-32.8
Enterprise Value $M66.1EPS $-0.5Operating Margin %-7,916.0Piotroski F-Score3
P/E(ttm)--Beneish M-Score-6.5Pre-tax Margin (%)-7,175.9Higher ROA y-yN
Price/Book6.010-y EBITDA Growth Rate %-2.7Quick Ratio1.1Cash flow > EarningsY
Price/Sales1255-y EBITDA Growth Rate %-17.9Current Ratio1.6Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-152.6Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-333.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M91.6ROIC % (ttm)-650.1Gross Margin Increase y-yN

Gurus Latest Trades with CVM

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

CVM is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


CVM: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
KERSTEN GEERT RCEO 2014-10-13Buy14,999$0.77-2.6 view
KERSTEN GEERT RCEO 2013-12-30Buy300,000$0.625 view
KERSTEN GEERT RChief Executive 2013-10-09Buy8,400$0.79-5.06 view
YOUNG PETER RDirector 2013-06-19Buy25,000$0.24212.5 view
KERSTEN GEERT RChief Executive 2013-06-14Buy145,120$0.24212.5 view
KERSTEN GEERT RCEO 2013-05-20Buy40,000$0.25200 view
KERSTEN GEERT RCEO 2013-05-02Buy118,700$0.27177.78 view
YOUNG PETER RDirector 2013-03-27Buy25,000$0.23226.09 view
PRICHEP PATRICIA BSenior Vice President 2013-03-27Buy25,000$0.22240.91 view
KERSTEN GEERT RCEO 2013-03-26Buy348,125$0.21257.14 view

Press Releases about CVM :

    Quarterly/Annual Reports about CVM:

    News about CVM:

    Articles On GuruFocus.com
    Updated Coverage Report Focuses on CEL-SCI Corporation Jan 12 2015 
    Coverage Initiation Report Focuses on CEL-SCI Corporation Oct 15 2014 
    CELSCISci Corp Reports Operating Results (10-Q) Feb 09 2011 
    CELSCISci Corp Reports Operating Results (10-Q) Aug 16 2010 
    CELSCISci Corp Reports Operating Results (10-Q) May 17 2010 
    CELSCISci Corp Reports Operating Results (10-Q) Feb 12 2010 
    CELSCISci Corp Reports Operating Results (10-Q/A) Feb 01 2010 
    CELSCISci Corp Reports Operating Results (10-Q/A) Feb 01 2010 
    CELSCISci Corp Reports Operating Results (10-Q/A) Jan 29 2010 
    CELSCISci Corp Reports Operating Results (10-K) Jan 13 2010 

    More From Other Websites
    NEW STORY CEL-SCI Reports May Patient Enrollment in Its Phase 3 Head and Neck Cancer Trial Jun 01 2015
    10:06 am CEL-SCI Corp announces that 26 patients were enrolled in its ongoing Phase III trial of... Jun 01 2015
    CEL-SCI Reports May Patient Enrollment in Its Phase 3 Head and Neck Cancer Trial Jun 01 2015
    NEW STORY CEL-SCI Announces Closing of Public Offering for Gross Proceeds of $16 Million May 29 2015
    CEL SCI CORP Files SEC form 8-K, Entry into a Material Definitive Agreement May 29 2015
    CEL-SCI Announces Closing of Public Offering for Gross Proceeds of $16 Million May 29 2015
    NEW STORY CEL-SCI to Present at the 2015 Marcum MicroCap Conference May 27 2015
    CEL-SCI to Present at the 2015 Marcum MicroCap Conference May 27 2015
    CEL SCI CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial... May 26 2015
    NEW STORY CEL-SCI Prices Up To $16 Million Public Offering of Common Stock and Warrants May 22 2015
    CEL-SCI Prices up to $16 Million Public Offering of Common Stock and Warrants May 22 2015
    NEW STORY CEL-SCI Announces Proposed Public Offering of Common Stock and Warrants May 21 2015
    CEL-SCI Announces Proposed Public Offering of Common Stock and Warrants May 21 2015
    CEL SCI CORP Financials May 19 2015
    NEW STORY CEL-SCI Receives Authorization to Conduct Its Phase 3 Multikine Trial in Italy May 13 2015
    CEL SCI CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits May 13 2015
    CEL-SCI Receives Authorization to Conduct Its Phase 3 Multikine Trial in Italy May 13 2015
    NEW STORY CEL-SCI Receives Authorization to Conduct Its Phase 3 Multikine Trial in Spain May 11 2015
    CEL SCI CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits May 11 2015
    CEL-SCI Receives Authorization to Conduct Its Phase 3 Multikine Trial in Spain May 11 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK